Ventilator Associated Pneumonia: Clinical Trials

22 trials for Ventilator Associated Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 4 terminated, 4 unknown, 2 recruiting. 22 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 322Completed 10, Terminated 4, Unknown 4, Recruiting 2, Not yet recruiting 1, Withdrawn 1
Phase 26Completed 2, Unknown 2, Not yet recruiting 1, Terminated 1

Follow Ventilator Associated Pneumonia: new trials by email Literature Review of Ventilator Associated Pneumonia trials Research Report on Ventilator Associated Pneumonia

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
colistimethate sodium, 0.9% Saline - Ventilator Associated Pneumonia
Phase 2 / Phase 3Not yet recruitingUniversity Hospital Fattouma Bourguiba4002027-01-012026-10-08
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Acyclovir - Pneumonia, Viral, Ventilator Associated Pneumonia
Phase 3RecruitingJena University Hospital6162024-02-202026-07-23
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
cotrimoxazole, standard antibiotic therapy - Ventilator Associated Pneumonia
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris6282023-10-192025-05-20
Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia
Povidone-Iodine, Saline spray - Ventilator Associated Pneumonia
Phase 2 / Phase 3CompletedMenoufia University782023-06-242023-11-27
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
Suvratoxumab, Placebo - Ventilator Associated Pneumonia, Staphylococcus Aureus
Phase 3TerminatedAridis Pharmaceuticals, Inc.242022-09-022025-03-24
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
2% chlorhexidine digluconate solution with surface-active agents, Usual Baths - Health Care Associated Infection, Ventilator Associated Pneumonia
Phase 3CompletedHospital do Coracao157302022-08-032024-06-13
Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia
Aztreonam lysine, Aerogen Solo, CombiHaler - Ventilator Associated Pneumonia, Prevention
Phase 2 / Phase 3TerminatedHospital Universitari Joan XXIII de Tarragona.92019-03-192021-07-01
Different Oral Colonization of Gram-negative Bacteria in ICU Patients When Using Chlorhexidine at 0.12% Versus Chlorhexidine at 2.0%
Chlorhexidine gluconate at 2%, Chlorhexidine gluconate at 0.12% - Chlorhexidine, Ventilator Associated Pneumonia
Phase 3UnknownUniversidad de Guanajuato742019-02-012019-03-11
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
ATM-AVI, MTZ, MER - Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia
Phase 3CompletedPfizer4222018-04-052024-12-10
Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection
Reducing Antibiotics treatment duration, Standard Antibiotics treatment duration - Ventilator Associated Pneumonia, Pneumonia, Bacterial
Phase 3CompletedUniversity of Oxford4602018-02-212024-01-18
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
SDD Oral Paste, SDD Gastric Suspension, Intravenous Antibiotic - Critical Illness, Sepsis
Phase 3CompletedThe George Institute200102017-05-012023-08-14
The Effect of Colistin Inhalation on Ventilator Associated Pneumonia
Colistin, Carbapenem + Aminoglycoside/ Quinolone - Ventilator Associated Pneumonia
Phase 2 / Phase 3CompletedNourhan Hassan Osama Thuraya Mohamed402016-01-022018-08-09
Air-impingement Manipulation to Clear Subglottic Secretion to Prevent VAP in Prolonged Intubated Patients
Manual air-impingement operation, subglottic secretion drainage - Ventilator Associated Pneumonia
Phase 3UnknownBeijing Chao Yang Hospital2202016-01-012015-12-16
Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections
Neomycin Colistin Nystatin Vancomycin - Bacteremia Associated With Intravascular Line, Ventilator Associated Pneumonia
Phase 2 / Phase 3UnknownRambam Health Care Campus24002013-06-012013-02-26
The Gravity-VAP (Ventilator-Associated Pneumonia) Trial
lateral-Trendelenburg position - Ventilator Associated Pneumonia
Phase 3TerminatedPoliclinico Hospital8002010-11-012017-06-16
Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation
Nebulized amikacin, Intravenous amikacin, Placebo nebulization - Ventilator Associated Pneumonia
Phase 2 / Phase 3UnknownAssociation Pour La Promotion A Tours De La Reanimation Medicale242009-01-012009-03-16
Study of Povidone Iodine to Reduce Pulmonary Infection in Head Trauma and Cerebral Hemorrhage in Intensive Care Unit
povidone iodine, Placebo - Ventilator Associated Pneumonia
Phase 3TerminatedRennes University Hospital1792008-04-012012-07-06
Role of Oral Chlorhexidine Gel in Prevention of Ventilator Associated Pneumonia
Chlorhexidine gel, Placebo gel - Ventilator Associated Pneumonia
Phase 3CompletedAll India Institute of Medical Sciences862007-11-012011-03-23
Bronchoscopy vs. Clinical Pulmonary Infection Score Guided Approach in Suspected Ventilator-Associated Pneumonia (VAP)
Bronchoscopy, Clinical pulmonary infection score (CPIS) - Ventilator Associated Pneumonia
Phase 3WithdrawnMayo Clinic2007-01-012023-09-26
Oral Hygiene With Chlorhexidine and Incidence of Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery
oral hygiene, placebo - Ventilator Associated Pneumonia, Nosocomial Pneumonia
Phase 3CompletedUniversity of Sao Paulo1602006-02-012009-01-27

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Pneumonia, Ventilator-Associated (22)  ·  Pneumonia (5)  ·  Healthcare-Associated Pneumonia (2)  ·  Bacteremia (1)  ·  Community-Acquired Pneumonia (1)  ·  Critical Illness (1)  ·  Cross Infection (1)  ·  Herpes Simplex (1)  ·  Pneumonia, Bacterial (1)  ·  Pneumonia, Viral (1)  ·  Sepsis (1)  ·  Shock, Septic (1)  ·  Staphylococcal Infections (1)

Broader conditions

Disease Attributes (22)  ·  Iatrogenic Disease (22)  ·  Infections (22)  ·  Lung Diseases (22)  ·  Pathologic Processes (22)  ·  Pathological Conditions, Signs and Symptoms (22)  ·  Respiratory Tract Diseases (22)  ·  Respiratory Tract Infections (22)  ·  Cross Infection (21)  ·  Healthcare-Associated Pneumonia (20)  ·  Pneumonia (17)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Inflammation (2)  ·  Systemic Inflammatory Response Syndrome (2)

Interventions

Colistin (4)  ·  Bronchoscopy (2)  ·  Povidone-Iodine (2)  ·  Saline Solution (2)  ·  Acyclovir (1)  ·  Aminoglycosides (1)  ·  Carbapenems (1)  ·  Cefotaxime (1)  ·  Ceftriaxone (1)  ·  Ciprofloxacin (1)  ·  Glycyrrhizic Acid (1)  ·  Neomycin (1)  ·  Nystatin (1)  ·  Oral Hygiene (1)  ·  Quinolones (1)

Sponsors

All India Institute of Medical Sciences (1)  ·  Aridis Pharmaceuticals, Inc. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Association Pour La Promotion A Tours De La Reanimation Medicale (1)  ·  Beijing Chao Yang Hospital (1)  ·  Creighton University (1)  ·  Hospital Universitari Joan XXIII de Tarragona. (1)  ·  Hospital do Coracao (1)  ·  Jena University Hospital (1)  ·  Mayo Clinic (1)  ·  Menoufia University (1)  ·  Nourhan Hassan Osama Thuraya Mohamed (1)  ·  Pfizer (1)  ·  Policlinico Hospital (1)  ·  Rambam Health Care Campus (1)

Countries

France (4)  ·  Spain (4)  ·  India (3)  ·  Israel (3)  ·  Greece (2)  ·  Italy (2)  ·  Mexico (2)  ·  Thailand (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)

Top investigators

Alexandre B Cavalcanti, M.D (1)  ·  Anil Sachdev, MD (1)  ·  Anthony Gordon, MD FRCA (1)  ·  Bekele Afessa, MD (1)  ·  Brian Cuthbertson, MD FRCA (1)  ·  Bruno Laviolle, MD (1)  ·  Bruno M Tomazini, M.D (1)  ·  Hazem E Elsersy, MD (1)  ·  Jiwei Li (1)  ·  John Myburgh, MBBCh PhD (1)  ·  Jose A Alvarez, PhD (1)  ·  Lee Morrow, MD (1)  ·  Mical Paul, Prof. (1)

Results publications

PMID 10816031, PMID 17872488, PMID 18641114, PMID 20522788, PMID 20936977, PMID 21129208, PMID 21558772, PMID 22186217, PMID 22760426, PMID 23352693, PMID 23583261, PMID 23727136, PMID 24105456, PMID 24207137, PMID 24969718, PMID 25050644, PMID 25343570, PMID 26472037, PMID 27080532, PMID 29041861, PMID 29149418, PMID 33986070, PMID 36286097, PMID 37982826, PMID 38045525, PMID 38252170, PMID 38272050, PMID 38670599, PMID 39389071, PMID 40530972, PMID 41159880, PMID 41269522, PMID 41732706, PMID 42642777, PMID 8888088

NIH funding

2017 (1)